FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals NY LLC under ANDA 078071.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder
• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)